Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03612531 · ClinicalTrials.gov registry record · NA

Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors

A NA study of Dysphagia and Head and Neck Carcinoma, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT03612531 is a NA study of Dysphagia and Head and Neck Carcinoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 24 participants, below the 171-participant average among 35 other Dysphagia trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03612531, a NA study of Dysphagia and Head and Neck Carcinoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well manual therapy works in treating fibrosis-related late effect dysphagia in head and neck cancer survivors. Manual therapy is the use of massage and stretching exercises to increase blood flow and muscle movement in the neck, throat, jaw, and mouth, which may help to improve swallowing ability and range of motion in participants who have had treatment for head and neck cancer.

Interventions

  • PROCEDURE Manual Therapy

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2018-08-06
Est. Completion 2025-12-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT03612531

The ClinicalTrials.gov registry entry for NCT03612531 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 171-participant average among 35 other Dysphagia trials with a reported enrollment target (86% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Dysphagia appearing as the primary indexed condition, and to 1 intervention - of which Manual Therapy is the first listed.

NCT03612531 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03612531 about?

NCT03612531 is a clinical study titled "Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors". This trial studies how well manual therapy works in treating fibrosis-related late effect dysphagia in head and neck cancer survivors. Manual therapy is the use of massage and stretching exercises to increase blood flow and muscle movement in the neck, throat, jaw, and mouth, which may help to impro...

What is the current status of trial NCT03612531?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2018-08-06. Estimated completion is 2025-12-31.

What conditions does trial NCT03612531 study?

This clinical trial studies the following conditions: Dysphagia, Head and Neck Carcinoma, Cancer Survivor, Fibrosis.

What interventions are being tested in trial NCT03612531?

The interventions under investigation include: Manual Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT03612531?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03612531 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dysphagia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.